nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Parkinson's disease—Clonazepam—epilepsy syndrome	0.201	0.554	CpDpCtD
Hyoscyamine—Parkinson's disease—Gabapentin—epilepsy syndrome	0.162	0.446	CpDpCtD
Hyoscyamine—CHRM3—epilepsy syndrome	0.152	0.371	CbGaD
Hyoscyamine—CHRM1—epilepsy syndrome	0.142	0.346	CbGaD
Hyoscyamine—CHRM2—epilepsy syndrome	0.116	0.283	CbGaD
Hyoscyamine—CHRM4—head—epilepsy syndrome	0.000218	0.0728	CbGeAlD
Hyoscyamine—Methylscopolamine bromide—CHRM3—epilepsy syndrome	0.000209	0.0524	CrCbGaD
Hyoscyamine—CHRM4—nervous system—epilepsy syndrome	0.000207	0.069	CbGeAlD
Hyoscyamine—CHRM2—forebrain—epilepsy syndrome	0.000205	0.0682	CbGeAlD
Hyoscyamine—CHRM4—central nervous system—epilepsy syndrome	0.000199	0.0665	CbGeAlD
Hyoscyamine—Methylscopolamine bromide—CHRM1—epilepsy syndrome	0.000195	0.0488	CrCbGaD
Hyoscyamine—CHRM2—telencephalon—epilepsy syndrome	0.000188	0.0627	CbGeAlD
Hyoscyamine—CHRM1—forebrain—epilepsy syndrome	0.000186	0.0621	CbGeAlD
Hyoscyamine—Cyclopentolate—CHRM3—epilepsy syndrome	0.000183	0.0459	CrCbGaD
Hyoscyamine—Scopolamine—CHRM3—epilepsy syndrome	0.000177	0.0445	CrCbGaD
Hyoscyamine—CHRM1—telencephalon—epilepsy syndrome	0.000171	0.0571	CbGeAlD
Hyoscyamine—Cyclopentolate—CHRM1—epilepsy syndrome	0.00017	0.0428	CrCbGaD
Hyoscyamine—CHRM3—forebrain—epilepsy syndrome	0.000167	0.0556	CbGeAlD
Hyoscyamine—Scopolamine—CHRM1—epilepsy syndrome	0.000165	0.0415	CrCbGaD
Hyoscyamine—Methylscopolamine bromide—CHRM2—epilepsy syndrome	0.000159	0.0399	CrCbGaD
Hyoscyamine—CHRM4—brain—epilepsy syndrome	0.000158	0.0528	CbGeAlD
Hyoscyamine—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000154	0.0386	CrCbGaD
Hyoscyamine—CHRM3—telencephalon—epilepsy syndrome	0.000153	0.0511	CbGeAlD
Hyoscyamine—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000143	0.036	CrCbGaD
Hyoscyamine—Cocaine—CHRM1—epilepsy syndrome	0.00014	0.0351	CrCbGaD
Hyoscyamine—Atropine—CHRM3—epilepsy syndrome	0.000138	0.0348	CrCbGaD
Hyoscyamine—Ipratropium bromide—CHRM3—epilepsy syndrome	0.000137	0.0344	CrCbGaD
Hyoscyamine—Scopolamine—CHRM2—epilepsy syndrome	0.000135	0.0339	CrCbGaD
Hyoscyamine—Atropine—CHRM1—epilepsy syndrome	0.000129	0.0324	CrCbGaD
Hyoscyamine—Ipratropium bromide—CHRM1—epilepsy syndrome	0.000128	0.0321	CrCbGaD
Hyoscyamine—Dolasetron—CYP2D6—epilepsy syndrome	0.00012	0.0301	CrCbGaD
Hyoscyamine—CHRM2—head—epilepsy syndrome	0.000117	0.0391	CbGeAlD
Hyoscyamine—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000117	0.0294	CrCbGaD
Hyoscyamine—Cyclopentolate—BCHE—epilepsy syndrome	0.000116	0.0291	CrCbGaD
Hyoscyamine—Cocaine—CHRM2—epilepsy syndrome	0.000114	0.0286	CrCbGaD
Hyoscyamine—CHRM2—nervous system—epilepsy syndrome	0.000111	0.037	CbGeAlD
Hyoscyamine—Granisetron—CYP2D6—epilepsy syndrome	0.00011	0.0275	CrCbGaD
Hyoscyamine—CHRM2—central nervous system—epilepsy syndrome	0.000107	0.0357	CbGeAlD
Hyoscyamine—CHRM1—head—epilepsy syndrome	0.000107	0.0356	CbGeAlD
Hyoscyamine—Atropine—CHRM2—epilepsy syndrome	0.000105	0.0265	CrCbGaD
Hyoscyamine—Benzatropine—CHRM1—epilepsy syndrome	0.000105	0.0263	CrCbGaD
Hyoscyamine—Ipratropium bromide—CHRM2—epilepsy syndrome	0.000104	0.0262	CrCbGaD
Hyoscyamine—CHRM1—nervous system—epilepsy syndrome	0.000101	0.0337	CbGeAlD
Hyoscyamine—Methylphenidate—SLC6A4—epilepsy syndrome	9.8e-05	0.0246	CrCbGaD
Hyoscyamine—Dexmethylphenidate—SLC6A4—epilepsy syndrome	9.8e-05	0.0246	CrCbGaD
Hyoscyamine—CHRM1—central nervous system—epilepsy syndrome	9.74e-05	0.0325	CbGeAlD
Hyoscyamine—CHRM3—head—epilepsy syndrome	9.55e-05	0.0318	CbGeAlD
Hyoscyamine—CHRM3—nervous system—epilepsy syndrome	9.05e-05	0.0302	CbGeAlD
Hyoscyamine—CHRM3—central nervous system—epilepsy syndrome	8.71e-05	0.0291	CbGeAlD
Hyoscyamine—Benzatropine—CHRM2—epilepsy syndrome	8.54e-05	0.0214	CrCbGaD
Hyoscyamine—CHRM2—brain—epilepsy syndrome	8.49e-05	0.0283	CbGeAlD
Hyoscyamine—CHRM1—brain—epilepsy syndrome	7.73e-05	0.0258	CbGeAlD
Hyoscyamine—Cocaine—SLC6A4—epilepsy syndrome	7.43e-05	0.0187	CrCbGaD
Hyoscyamine—CHRM3—brain—epilepsy syndrome	6.92e-05	0.0231	CbGeAlD
Hyoscyamine—Methylphenidate—CYP2D6—epilepsy syndrome	6.89e-05	0.0173	CrCbGaD
Hyoscyamine—Dexmethylphenidate—CYP2D6—epilepsy syndrome	6.89e-05	0.0173	CrCbGaD
Hyoscyamine—Benzatropine—CYP2C19—epilepsy syndrome	5.27e-05	0.0132	CrCbGaD
Hyoscyamine—Cocaine—CYP2D6—epilepsy syndrome	5.22e-05	0.0131	CrCbGaD
Hyoscyamine—Ipratropium bromide—CYP2D6—epilepsy syndrome	4.78e-05	0.012	CrCbGaD
Hyoscyamine—Scopolamine—ABCB1—epilepsy syndrome	4.41e-05	0.0111	CrCbGaD
Hyoscyamine—Benzatropine—CYP2D6—epilepsy syndrome	3.91e-05	0.00981	CrCbGaD
Hyoscyamine—Rash—Levetiracetam—epilepsy syndrome	3.23e-05	0.000202	CcSEcCtD
Hyoscyamine—Dermatitis—Levetiracetam—epilepsy syndrome	3.23e-05	0.000201	CcSEcCtD
Hyoscyamine—Asthenia—Zonisamide—epilepsy syndrome	3.23e-05	0.000201	CcSEcCtD
Hyoscyamine—Mental disorder—Gabapentin—epilepsy syndrome	3.23e-05	0.000201	CcSEcCtD
Hyoscyamine—Dry mouth—Valproic Acid—epilepsy syndrome	3.22e-05	0.000201	CcSEcCtD
Hyoscyamine—Agitation—Pregabalin—epilepsy syndrome	3.21e-05	0.0002	CcSEcCtD
Hyoscyamine—Headache—Levetiracetam—epilepsy syndrome	3.21e-05	0.0002	CcSEcCtD
Hyoscyamine—Erythema—Gabapentin—epilepsy syndrome	3.2e-05	0.0002	CcSEcCtD
Hyoscyamine—Angioedema—Pregabalin—epilepsy syndrome	3.19e-05	0.000199	CcSEcCtD
Hyoscyamine—Hypersensitivity—Clonazepam—epilepsy syndrome	3.19e-05	0.000199	CcSEcCtD
Hyoscyamine—Dizziness—Vigabatrin—epilepsy syndrome	3.19e-05	0.000199	CcSEcCtD
Hyoscyamine—Confusional state—Valproic Acid—epilepsy syndrome	3.18e-05	0.000199	CcSEcCtD
Hyoscyamine—Pruritus—Zonisamide—epilepsy syndrome	3.18e-05	0.000199	CcSEcCtD
Hyoscyamine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.17e-05	0.000198	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.16e-05	0.000197	CcSEcCtD
Hyoscyamine—Oedema—Valproic Acid—epilepsy syndrome	3.16e-05	0.000197	CcSEcCtD
Hyoscyamine—Urticaria—Lamotrigine—epilepsy syndrome	3.15e-05	0.000197	CcSEcCtD
Hyoscyamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000197	CcSEcCtD
Hyoscyamine—Bradycardia—Topiramate—epilepsy syndrome	3.15e-05	0.000197	CcSEcCtD
Hyoscyamine—Nausea—Propofol—epilepsy syndrome	3.15e-05	0.000197	CcSEcCtD
Hyoscyamine—Tension—Gabapentin—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Vomiting—Fosphenytoin—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Diarrhoea—Felbamate—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Vertigo—Pregabalin—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Abdominal pain—Lamotrigine—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Dysgeusia—Gabapentin—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Dizziness—Diazepam—epilepsy syndrome	3.14e-05	0.000196	CcSEcCtD
Hyoscyamine—Syncope—Pregabalin—epilepsy syndrome	3.13e-05	0.000196	CcSEcCtD
Hyoscyamine—Rash—Fosphenytoin—epilepsy syndrome	3.12e-05	0.000195	CcSEcCtD
Hyoscyamine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.12e-05	0.000194	CcSEcCtD
Hyoscyamine—Nervousness—Gabapentin—epilepsy syndrome	3.11e-05	0.000194	CcSEcCtD
Hyoscyamine—Asthenia—Clonazepam—epilepsy syndrome	3.11e-05	0.000194	CcSEcCtD
Hyoscyamine—Headache—Fosphenytoin—epilepsy syndrome	3.1e-05	0.000193	CcSEcCtD
Hyoscyamine—Palpitations—Pregabalin—epilepsy syndrome	3.09e-05	0.000193	CcSEcCtD
Hyoscyamine—Asthenia—Phenytoin—epilepsy syndrome	3.09e-05	0.000193	CcSEcCtD
Hyoscyamine—Nausea—Midazolam—epilepsy syndrome	3.08e-05	0.000192	CcSEcCtD
Hyoscyamine—Hallucination—Topiramate—epilepsy syndrome	3.08e-05	0.000192	CcSEcCtD
Hyoscyamine—Tachycardia—Valproic Acid—epilepsy syndrome	3.08e-05	0.000192	CcSEcCtD
Hyoscyamine—Diarrhoea—Zonisamide—epilepsy syndrome	3.08e-05	0.000192	CcSEcCtD
Hyoscyamine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.07e-05	0.000192	CcSEcCtD
Hyoscyamine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.07e-05	0.000192	CcSEcCtD
Hyoscyamine—Pruritus—Clonazepam—epilepsy syndrome	3.07e-05	0.000191	CcSEcCtD
Hyoscyamine—Vomiting—Vigabatrin—epilepsy syndrome	3.06e-05	0.000191	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.05e-05	0.00019	CcSEcCtD
Hyoscyamine—Pruritus—Phenytoin—epilepsy syndrome	3.05e-05	0.00019	CcSEcCtD
Hyoscyamine—Nausea—Levetiracetam—epilepsy syndrome	3.04e-05	0.00019	CcSEcCtD
Hyoscyamine—Rash—Vigabatrin—epilepsy syndrome	3.04e-05	0.00019	CcSEcCtD
Hyoscyamine—Dizziness—Felbamate—epilepsy syndrome	3.04e-05	0.00019	CcSEcCtD
Hyoscyamine—Dermatitis—Vigabatrin—epilepsy syndrome	3.04e-05	0.000189	CcSEcCtD
Hyoscyamine—Pruritus—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000189	CcSEcCtD
Hyoscyamine—Convulsion—Pregabalin—epilepsy syndrome	3.03e-05	0.000189	CcSEcCtD
Hyoscyamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.03e-05	0.000189	CcSEcCtD
Hyoscyamine—Vision blurred—Gabapentin—epilepsy syndrome	3.02e-05	0.000188	CcSEcCtD
Hyoscyamine—Headache—Vigabatrin—epilepsy syndrome	3.02e-05	0.000188	CcSEcCtD
Hyoscyamine—Vomiting—Diazepam—epilepsy syndrome	3.02e-05	0.000188	CcSEcCtD
Hyoscyamine—Rash—Diazepam—epilepsy syndrome	2.99e-05	0.000187	CcSEcCtD
Hyoscyamine—Dermatitis—Diazepam—epilepsy syndrome	2.99e-05	0.000187	CcSEcCtD
Hyoscyamine—Chest pain—Pregabalin—epilepsy syndrome	2.98e-05	0.000186	CcSEcCtD
Hyoscyamine—Dizziness—Zonisamide—epilepsy syndrome	2.97e-05	0.000186	CcSEcCtD
Hyoscyamine—Headache—Diazepam—epilepsy syndrome	2.97e-05	0.000186	CcSEcCtD
Hyoscyamine—Anxiety—Pregabalin—epilepsy syndrome	2.97e-05	0.000185	CcSEcCtD
Hyoscyamine—Diarrhoea—Clonazepam—epilepsy syndrome	2.96e-05	0.000185	CcSEcCtD
Hyoscyamine—Hypotension—Valproic Acid—epilepsy syndrome	2.95e-05	0.000184	CcSEcCtD
Hyoscyamine—Asthenia—Carbamazepine—epilepsy syndrome	2.95e-05	0.000184	CcSEcCtD
Hyoscyamine—Agitation—Gabapentin—epilepsy syndrome	2.95e-05	0.000184	CcSEcCtD
Hyoscyamine—Diarrhoea—Phenytoin—epilepsy syndrome	2.94e-05	0.000184	CcSEcCtD
Hyoscyamine—Nausea—Fosphenytoin—epilepsy syndrome	2.94e-05	0.000183	CcSEcCtD
Hyoscyamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.93e-05	0.000183	CcSEcCtD
Hyoscyamine—Angioedema—Gabapentin—epilepsy syndrome	2.93e-05	0.000183	CcSEcCtD
Hyoscyamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.93e-05	0.000183	CcSEcCtD
Hyoscyamine—Vomiting—Felbamate—epilepsy syndrome	2.92e-05	0.000182	CcSEcCtD
Hyoscyamine—Dry mouth—Pregabalin—epilepsy syndrome	2.91e-05	0.000182	CcSEcCtD
Hyoscyamine—Pruritus—Carbamazepine—epilepsy syndrome	2.91e-05	0.000181	CcSEcCtD
Hyoscyamine—Rash—Felbamate—epilepsy syndrome	2.9e-05	0.000181	CcSEcCtD
Hyoscyamine—Dermatitis—Felbamate—epilepsy syndrome	2.89e-05	0.000181	CcSEcCtD
Hyoscyamine—Vertigo—Gabapentin—epilepsy syndrome	2.88e-05	0.00018	CcSEcCtD
Hyoscyamine—Headache—Felbamate—epilepsy syndrome	2.88e-05	0.00018	CcSEcCtD
Hyoscyamine—Confusional state—Pregabalin—epilepsy syndrome	2.88e-05	0.000179	CcSEcCtD
Hyoscyamine—Flushing—Topiramate—epilepsy syndrome	2.87e-05	0.000179	CcSEcCtD
Hyoscyamine—Syncope—Gabapentin—epilepsy syndrome	2.87e-05	0.000179	CcSEcCtD
Hyoscyamine—Dizziness—Clonazepam—epilepsy syndrome	2.87e-05	0.000179	CcSEcCtD
Hyoscyamine—Nausea—Vigabatrin—epilepsy syndrome	2.86e-05	0.000179	CcSEcCtD
Hyoscyamine—Vomiting—Zonisamide—epilepsy syndrome	2.86e-05	0.000178	CcSEcCtD
Hyoscyamine—Insomnia—Valproic Acid—epilepsy syndrome	2.85e-05	0.000178	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.85e-05	0.000178	CcSEcCtD
Hyoscyamine—Oedema—Pregabalin—epilepsy syndrome	2.85e-05	0.000178	CcSEcCtD
Hyoscyamine—Asthenia—Lamotrigine—epilepsy syndrome	2.85e-05	0.000178	CcSEcCtD
Hyoscyamine—Dizziness—Phenytoin—epilepsy syndrome	2.85e-05	0.000178	CcSEcCtD
Hyoscyamine—Rash—Zonisamide—epilepsy syndrome	2.83e-05	0.000177	CcSEcCtD
Hyoscyamine—Palpitations—Gabapentin—epilepsy syndrome	2.83e-05	0.000177	CcSEcCtD
Hyoscyamine—Dermatitis—Zonisamide—epilepsy syndrome	2.83e-05	0.000177	CcSEcCtD
Hyoscyamine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.83e-05	0.000177	CcSEcCtD
Hyoscyamine—Nausea—Diazepam—epilepsy syndrome	2.82e-05	0.000176	CcSEcCtD
Hyoscyamine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.82e-05	0.000176	CcSEcCtD
Hyoscyamine—Headache—Zonisamide—epilepsy syndrome	2.82e-05	0.000176	CcSEcCtD
Hyoscyamine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.81e-05	0.000176	CcSEcCtD
Hyoscyamine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.81e-05	0.000175	CcSEcCtD
Hyoscyamine—Pruritus—Lamotrigine—epilepsy syndrome	2.81e-05	0.000175	CcSEcCtD
Hyoscyamine—Shock—Pregabalin—epilepsy syndrome	2.81e-05	0.000175	CcSEcCtD
Hyoscyamine—Somnolence—Valproic Acid—epilepsy syndrome	2.8e-05	0.000175	CcSEcCtD
Hyoscyamine—Tachycardia—Pregabalin—epilepsy syndrome	2.78e-05	0.000174	CcSEcCtD
Hyoscyamine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.78e-05	0.000173	CcSEcCtD
Hyoscyamine—Convulsion—Gabapentin—epilepsy syndrome	2.78e-05	0.000173	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.76e-05	0.000172	CcSEcCtD
Hyoscyamine—Vomiting—Clonazepam—epilepsy syndrome	2.76e-05	0.000172	CcSEcCtD
Hyoscyamine—Vomiting—Phenytoin—epilepsy syndrome	2.74e-05	0.000171	CcSEcCtD
Hyoscyamine—Rash—Clonazepam—epilepsy syndrome	2.73e-05	0.00017	CcSEcCtD
Hyoscyamine—Dermatitis—Clonazepam—epilepsy syndrome	2.73e-05	0.00017	CcSEcCtD
Hyoscyamine—Chest pain—Gabapentin—epilepsy syndrome	2.73e-05	0.00017	CcSEcCtD
Hyoscyamine—Nausea—Felbamate—epilepsy syndrome	2.73e-05	0.00017	CcSEcCtD
Hyoscyamine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.72e-05	0.00017	CcSEcCtD
Hyoscyamine—Fatigue—Valproic Acid—epilepsy syndrome	2.72e-05	0.00017	CcSEcCtD
Hyoscyamine—Anxiety—Gabapentin—epilepsy syndrome	2.72e-05	0.00017	CcSEcCtD
Hyoscyamine—Dizziness—Carbamazepine—epilepsy syndrome	2.72e-05	0.00017	CcSEcCtD
Hyoscyamine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.72e-05	0.00017	CcSEcCtD
Hyoscyamine—Headache—Clonazepam—epilepsy syndrome	2.71e-05	0.000169	CcSEcCtD
Hyoscyamine—Rash—Phenytoin—epilepsy syndrome	2.71e-05	0.000169	CcSEcCtD
Hyoscyamine—Mental disorder—Topiramate—epilepsy syndrome	2.71e-05	0.000169	CcSEcCtD
Hyoscyamine—Dermatitis—Phenytoin—epilepsy syndrome	2.71e-05	0.000169	CcSEcCtD
Hyoscyamine—Rash—Oxcarbazepine—epilepsy syndrome	2.7e-05	0.000168	CcSEcCtD
Hyoscyamine—Pain—Valproic Acid—epilepsy syndrome	2.7e-05	0.000168	CcSEcCtD
Hyoscyamine—Constipation—Valproic Acid—epilepsy syndrome	2.7e-05	0.000168	CcSEcCtD
Hyoscyamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.7e-05	0.000168	CcSEcCtD
Hyoscyamine—Headache—Phenytoin—epilepsy syndrome	2.7e-05	0.000168	CcSEcCtD
Hyoscyamine—Erythema—Topiramate—epilepsy syndrome	2.7e-05	0.000168	CcSEcCtD
Hyoscyamine—Headache—Oxcarbazepine—epilepsy syndrome	2.68e-05	0.000167	CcSEcCtD
Hyoscyamine—Nausea—Zonisamide—epilepsy syndrome	2.67e-05	0.000167	CcSEcCtD
Hyoscyamine—Dry mouth—Gabapentin—epilepsy syndrome	2.67e-05	0.000167	CcSEcCtD
Hyoscyamine—Hypotension—Pregabalin—epilepsy syndrome	2.67e-05	0.000166	CcSEcCtD
Hyoscyamine—Tension—Topiramate—epilepsy syndrome	2.65e-05	0.000165	CcSEcCtD
Hyoscyamine—Dysgeusia—Topiramate—epilepsy syndrome	2.64e-05	0.000165	CcSEcCtD
Hyoscyamine—Confusional state—Gabapentin—epilepsy syndrome	2.64e-05	0.000165	CcSEcCtD
Hyoscyamine—Dizziness—Lamotrigine—epilepsy syndrome	2.63e-05	0.000164	CcSEcCtD
Hyoscyamine—Nervousness—Topiramate—epilepsy syndrome	2.62e-05	0.000163	CcSEcCtD
Hyoscyamine—Oedema—Gabapentin—epilepsy syndrome	2.62e-05	0.000163	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.62e-05	0.000163	CcSEcCtD
Hyoscyamine—Vomiting—Carbamazepine—epilepsy syndrome	2.61e-05	0.000163	CcSEcCtD
Hyoscyamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.6e-05	0.000162	CcSEcCtD
Hyoscyamine—Rash—Carbamazepine—epilepsy syndrome	2.59e-05	0.000162	CcSEcCtD
Hyoscyamine—Dermatitis—Carbamazepine—epilepsy syndrome	2.59e-05	0.000162	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.58e-05	0.000161	CcSEcCtD
Hyoscyamine—Insomnia—Pregabalin—epilepsy syndrome	2.58e-05	0.000161	CcSEcCtD
Hyoscyamine—Nausea—Clonazepam—epilepsy syndrome	2.57e-05	0.000161	CcSEcCtD
Hyoscyamine—Headache—Carbamazepine—epilepsy syndrome	2.57e-05	0.000161	CcSEcCtD
Hyoscyamine—Shock—Gabapentin—epilepsy syndrome	2.57e-05	0.000161	CcSEcCtD
Hyoscyamine—Nausea—Phenytoin—epilepsy syndrome	2.56e-05	0.00016	CcSEcCtD
Hyoscyamine—Tachycardia—Gabapentin—epilepsy syndrome	2.55e-05	0.000159	CcSEcCtD
Hyoscyamine—Dyspnoea—Pregabalin—epilepsy syndrome	2.54e-05	0.000159	CcSEcCtD
Hyoscyamine—Nausea—Oxcarbazepine—epilepsy syndrome	2.54e-05	0.000159	CcSEcCtD
Hyoscyamine—Vision blurred—Topiramate—epilepsy syndrome	2.54e-05	0.000159	CcSEcCtD
Hyoscyamine—Somnolence—Pregabalin—epilepsy syndrome	2.54e-05	0.000158	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.53e-05	0.000158	CcSEcCtD
Hyoscyamine—Vomiting—Lamotrigine—epilepsy syndrome	2.52e-05	0.000158	CcSEcCtD
Hyoscyamine—Urticaria—Valproic Acid—epilepsy syndrome	2.51e-05	0.000156	CcSEcCtD
Hyoscyamine—Rash—Lamotrigine—epilepsy syndrome	2.5e-05	0.000156	CcSEcCtD
Hyoscyamine—Dermatitis—Lamotrigine—epilepsy syndrome	2.5e-05	0.000156	CcSEcCtD
Hyoscyamine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.49e-05	0.000156	CcSEcCtD
Hyoscyamine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.49e-05	0.000156	CcSEcCtD
Hyoscyamine—Headache—Lamotrigine—epilepsy syndrome	2.49e-05	0.000155	CcSEcCtD
Hyoscyamine—Agitation—Topiramate—epilepsy syndrome	2.48e-05	0.000155	CcSEcCtD
Hyoscyamine—Fatigue—Pregabalin—epilepsy syndrome	2.46e-05	0.000153	CcSEcCtD
Hyoscyamine—Hypotension—Gabapentin—epilepsy syndrome	2.44e-05	0.000153	CcSEcCtD
Hyoscyamine—Nausea—Carbamazepine—epilepsy syndrome	2.44e-05	0.000152	CcSEcCtD
Hyoscyamine—Pain—Pregabalin—epilepsy syndrome	2.44e-05	0.000152	CcSEcCtD
Hyoscyamine—Constipation—Pregabalin—epilepsy syndrome	2.44e-05	0.000152	CcSEcCtD
Hyoscyamine—Vertigo—Topiramate—epilepsy syndrome	2.42e-05	0.000151	CcSEcCtD
Hyoscyamine—Syncope—Topiramate—epilepsy syndrome	2.42e-05	0.000151	CcSEcCtD
Hyoscyamine—Palpitations—Topiramate—epilepsy syndrome	2.38e-05	0.000149	CcSEcCtD
Hyoscyamine—Loss of consciousness—Topiramate—epilepsy syndrome	2.37e-05	0.000148	CcSEcCtD
Hyoscyamine—Insomnia—Gabapentin—epilepsy syndrome	2.37e-05	0.000148	CcSEcCtD
Hyoscyamine—Nausea—Lamotrigine—epilepsy syndrome	2.36e-05	0.000147	CcSEcCtD
Hyoscyamine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.35e-05	0.000147	CcSEcCtD
Hyoscyamine—Convulsion—Topiramate—epilepsy syndrome	2.34e-05	0.000146	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.33e-05	0.000146	CcSEcCtD
Hyoscyamine—Dyspnoea—Gabapentin—epilepsy syndrome	2.33e-05	0.000146	CcSEcCtD
Hyoscyamine—Somnolence—Gabapentin—epilepsy syndrome	2.33e-05	0.000145	CcSEcCtD
Hyoscyamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.32e-05	0.000145	CcSEcCtD
Hyoscyamine—Dyspepsia—Gabapentin—epilepsy syndrome	2.3e-05	0.000144	CcSEcCtD
Hyoscyamine—Chest pain—Topiramate—epilepsy syndrome	2.3e-05	0.000143	CcSEcCtD
Hyoscyamine—Anxiety—Topiramate—epilepsy syndrome	2.29e-05	0.000143	CcSEcCtD
Hyoscyamine—Urticaria—Pregabalin—epilepsy syndrome	2.27e-05	0.000141	CcSEcCtD
Hyoscyamine—Asthenia—Valproic Acid—epilepsy syndrome	2.26e-05	0.000141	CcSEcCtD
Hyoscyamine—Fatigue—Gabapentin—epilepsy syndrome	2.26e-05	0.000141	CcSEcCtD
Hyoscyamine—Abdominal pain—Pregabalin—epilepsy syndrome	2.25e-05	0.000141	CcSEcCtD
Hyoscyamine—Body temperature increased—Pregabalin—epilepsy syndrome	2.25e-05	0.000141	CcSEcCtD
Hyoscyamine—Dry mouth—Topiramate—epilepsy syndrome	2.25e-05	0.00014	CcSEcCtD
Hyoscyamine—Pain—Gabapentin—epilepsy syndrome	2.24e-05	0.00014	CcSEcCtD
Hyoscyamine—Constipation—Gabapentin—epilepsy syndrome	2.24e-05	0.00014	CcSEcCtD
Hyoscyamine—Pruritus—Valproic Acid—epilepsy syndrome	2.23e-05	0.000139	CcSEcCtD
Hyoscyamine—Confusional state—Topiramate—epilepsy syndrome	2.22e-05	0.000138	CcSEcCtD
Hyoscyamine—Oedema—Topiramate—epilepsy syndrome	2.2e-05	0.000137	CcSEcCtD
Hyoscyamine—Shock—Topiramate—epilepsy syndrome	2.17e-05	0.000135	CcSEcCtD
Hyoscyamine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.16e-05	0.000135	CcSEcCtD
Hyoscyamine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.16e-05	0.000135	CcSEcCtD
Hyoscyamine—Tachycardia—Topiramate—epilepsy syndrome	2.15e-05	0.000134	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.14e-05	0.000133	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.13e-05	0.000133	CcSEcCtD
Hyoscyamine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.1e-05	0.000131	CcSEcCtD
Hyoscyamine—Dizziness—Valproic Acid—epilepsy syndrome	2.09e-05	0.00013	CcSEcCtD
Hyoscyamine—Urticaria—Gabapentin—epilepsy syndrome	2.08e-05	0.00013	CcSEcCtD
Hyoscyamine—Abdominal pain—Gabapentin—epilepsy syndrome	2.07e-05	0.000129	CcSEcCtD
Hyoscyamine—Body temperature increased—Gabapentin—epilepsy syndrome	2.07e-05	0.000129	CcSEcCtD
Hyoscyamine—Hypotension—Topiramate—epilepsy syndrome	2.06e-05	0.000128	CcSEcCtD
Hyoscyamine—Asthenia—Pregabalin—epilepsy syndrome	2.05e-05	0.000128	CcSEcCtD
Hyoscyamine—Pruritus—Pregabalin—epilepsy syndrome	2.02e-05	0.000126	CcSEcCtD
Hyoscyamine—Vomiting—Valproic Acid—epilepsy syndrome	2.01e-05	0.000125	CcSEcCtD
Hyoscyamine—Insomnia—Topiramate—epilepsy syndrome	1.99e-05	0.000124	CcSEcCtD
Hyoscyamine—Rash—Valproic Acid—epilepsy syndrome	1.99e-05	0.000124	CcSEcCtD
Hyoscyamine—Dermatitis—Valproic Acid—epilepsy syndrome	1.99e-05	0.000124	CcSEcCtD
Hyoscyamine—Headache—Valproic Acid—epilepsy syndrome	1.98e-05	0.000123	CcSEcCtD
Hyoscyamine—Dyspnoea—Topiramate—epilepsy syndrome	1.96e-05	0.000122	CcSEcCtD
Hyoscyamine—Somnolence—Topiramate—epilepsy syndrome	1.96e-05	0.000122	CcSEcCtD
Hyoscyamine—Diarrhoea—Pregabalin—epilepsy syndrome	1.95e-05	0.000122	CcSEcCtD
Hyoscyamine—Dyspepsia—Topiramate—epilepsy syndrome	1.94e-05	0.000121	CcSEcCtD
Hyoscyamine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.93e-05	0.00012	CcSEcCtD
Hyoscyamine—Fatigue—Topiramate—epilepsy syndrome	1.9e-05	0.000118	CcSEcCtD
Hyoscyamine—Dizziness—Pregabalin—epilepsy syndrome	1.89e-05	0.000118	CcSEcCtD
Hyoscyamine—Constipation—Topiramate—epilepsy syndrome	1.88e-05	0.000117	CcSEcCtD
Hyoscyamine—Pain—Topiramate—epilepsy syndrome	1.88e-05	0.000117	CcSEcCtD
Hyoscyamine—Asthenia—Gabapentin—epilepsy syndrome	1.88e-05	0.000117	CcSEcCtD
Hyoscyamine—Nausea—Valproic Acid—epilepsy syndrome	1.87e-05	0.000117	CcSEcCtD
Hyoscyamine—Pruritus—Gabapentin—epilepsy syndrome	1.85e-05	0.000115	CcSEcCtD
Hyoscyamine—Vomiting—Pregabalin—epilepsy syndrome	1.81e-05	0.000113	CcSEcCtD
Hyoscyamine—Feeling abnormal—Topiramate—epilepsy syndrome	1.81e-05	0.000113	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.8e-05	0.000112	CcSEcCtD
Hyoscyamine—Rash—Pregabalin—epilepsy syndrome	1.8e-05	0.000112	CcSEcCtD
Hyoscyamine—Dermatitis—Pregabalin—epilepsy syndrome	1.8e-05	0.000112	CcSEcCtD
Hyoscyamine—Diarrhoea—Gabapentin—epilepsy syndrome	1.79e-05	0.000112	CcSEcCtD
Hyoscyamine—Headache—Pregabalin—epilepsy syndrome	1.79e-05	0.000112	CcSEcCtD
Hyoscyamine—Urticaria—Topiramate—epilepsy syndrome	1.75e-05	0.000109	CcSEcCtD
Hyoscyamine—Body temperature increased—Topiramate—epilepsy syndrome	1.74e-05	0.000109	CcSEcCtD
Hyoscyamine—Abdominal pain—Topiramate—epilepsy syndrome	1.74e-05	0.000109	CcSEcCtD
Hyoscyamine—Dizziness—Gabapentin—epilepsy syndrome	1.73e-05	0.000108	CcSEcCtD
Hyoscyamine—Nausea—Pregabalin—epilepsy syndrome	1.69e-05	0.000106	CcSEcCtD
Hyoscyamine—Vomiting—Gabapentin—epilepsy syndrome	1.66e-05	0.000104	CcSEcCtD
Hyoscyamine—Rash—Gabapentin—epilepsy syndrome	1.65e-05	0.000103	CcSEcCtD
Hyoscyamine—Dermatitis—Gabapentin—epilepsy syndrome	1.65e-05	0.000103	CcSEcCtD
Hyoscyamine—Headache—Gabapentin—epilepsy syndrome	1.64e-05	0.000102	CcSEcCtD
Hyoscyamine—Hypersensitivity—Topiramate—epilepsy syndrome	1.62e-05	0.000101	CcSEcCtD
Hyoscyamine—Asthenia—Topiramate—epilepsy syndrome	1.58e-05	9.85e-05	CcSEcCtD
Hyoscyamine—Pruritus—Topiramate—epilepsy syndrome	1.56e-05	9.72e-05	CcSEcCtD
Hyoscyamine—Nausea—Gabapentin—epilepsy syndrome	1.55e-05	9.7e-05	CcSEcCtD
Hyoscyamine—Diarrhoea—Topiramate—epilepsy syndrome	1.51e-05	9.4e-05	CcSEcCtD
Hyoscyamine—Dizziness—Topiramate—epilepsy syndrome	1.46e-05	9.08e-05	CcSEcCtD
Hyoscyamine—Vomiting—Topiramate—epilepsy syndrome	1.4e-05	8.73e-05	CcSEcCtD
Hyoscyamine—Rash—Topiramate—epilepsy syndrome	1.39e-05	8.66e-05	CcSEcCtD
Hyoscyamine—Dermatitis—Topiramate—epilepsy syndrome	1.39e-05	8.65e-05	CcSEcCtD
Hyoscyamine—Headache—Topiramate—epilepsy syndrome	1.38e-05	8.6e-05	CcSEcCtD
Hyoscyamine—Nausea—Topiramate—epilepsy syndrome	1.31e-05	8.16e-05	CcSEcCtD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	6.86e-06	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	6.84e-06	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	6.78e-06	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	6.72e-06	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.72e-06	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—S100B—epilepsy syndrome	6.71e-06	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	6.7e-06	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.7e-06	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	6.67e-06	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SOCS3—epilepsy syndrome	6.65e-06	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—BCHE—epilepsy syndrome	6.64e-06	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	6.63e-06	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDC42—epilepsy syndrome	6.63e-06	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.63e-06	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	6.55e-06	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	6.55e-06	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	6.53e-06	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	6.53e-06	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	6.46e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	6.46e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AVP—epilepsy syndrome	6.42e-06	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	6.37e-06	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	6.35e-06	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	6.33e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	6.32e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	6.3e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	6.3e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	6.3e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	6.3e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	6.3e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	6.29e-06	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PLCB1—epilepsy syndrome	6.26e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TH—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	6.24e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	6.23e-06	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	6.21e-06	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	6.15e-06	9.94e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	6.1e-06	9.85e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	6.08e-06	9.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HES1—epilepsy syndrome	6.07e-06	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	6.02e-06	9.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FYN—epilepsy syndrome	5.91e-06	9.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.89e-06	9.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—H2AFX—epilepsy syndrome	5.88e-06	9.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MEF2C—epilepsy syndrome	5.87e-06	9.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	5.87e-06	9.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	5.87e-06	9.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.87e-06	9.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	5.85e-06	9.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	5.85e-06	9.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.81e-06	9.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	5.8e-06	9.37e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	5.8e-06	9.37e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	5.79e-06	9.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	5.77e-06	9.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	5.71e-06	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	5.71e-06	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	5.71e-06	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	5.71e-06	9.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	5.7e-06	9.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SST—epilepsy syndrome	5.7e-06	9.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	5.7e-06	9.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—YWHAZ—epilepsy syndrome	5.68e-06	9.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	5.66e-06	9.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	5.65e-06	9.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	5.64e-06	9.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	5.64e-06	9.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	5.64e-06	9.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NGF—epilepsy syndrome	5.61e-06	9.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	5.59e-06	9.03e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	5.59e-06	9.03e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	5.57e-06	9.01e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	5.57e-06	9e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	5.55e-06	8.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	5.52e-06	8.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	5.5e-06	8.88e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR5—epilepsy syndrome	5.46e-06	8.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	5.37e-06	8.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	5.37e-06	8.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	5.36e-06	8.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	5.35e-06	8.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	5.35e-06	8.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	5.35e-06	8.64e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	5.35e-06	8.64e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	5.34e-06	8.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	5.33e-06	8.61e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	5.33e-06	8.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	5.31e-06	8.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	5.3e-06	8.57e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.3e-06	8.57e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	5.3e-06	8.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.28e-06	8.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	5.27e-06	8.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	5.27e-06	8.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.26e-06	8.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	5.26e-06	8.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	5.26e-06	8.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	5.25e-06	8.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	5.24e-06	8.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	5.21e-06	8.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	5.21e-06	8.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	5.21e-06	8.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	5.19e-06	8.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	5.14e-06	8.31e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CAT—epilepsy syndrome	5.14e-06	8.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	5.13e-06	8.29e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	5.08e-06	8.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	5.08e-06	8.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	5.07e-06	8.19e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	5e-06	8.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.99e-06	8.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.98e-06	8.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	4.97e-06	8.03e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.93e-06	7.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.9e-06	7.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.89e-06	7.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.87e-06	7.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	4.87e-06	7.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.86e-06	7.85e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.84e-06	7.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.81e-06	7.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.79e-06	7.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.77e-06	7.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.77e-06	7.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4.75e-06	7.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.73e-06	7.64e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.7e-06	7.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	4.68e-06	7.57e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	4.67e-06	7.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.65e-06	7.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4.53e-06	7.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	4.51e-06	7.29e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	4.48e-06	7.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	4.47e-06	7.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	4.47e-06	7.22e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	4.47e-06	7.22e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	4.46e-06	7.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	4.43e-06	7.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	4.42e-06	7.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	4.33e-06	7e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	4.32e-06	6.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	4.27e-06	6.91e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	4.27e-06	6.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	4.18e-06	6.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	4.09e-06	6.62e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	4.08e-06	6.59e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGT—epilepsy syndrome	4.08e-06	6.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	4.04e-06	6.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOE—epilepsy syndrome	3.99e-06	6.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.98e-06	6.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.97e-06	6.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.97e-06	6.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.96e-06	6.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.95e-06	6.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.95e-06	6.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.93e-06	6.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.92e-06	6.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.91e-06	6.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.83e-06	6.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.82e-06	6.16e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.78e-06	6.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.78e-06	6.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	3.77e-06	6.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.77e-06	6.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.74e-06	6.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.68e-06	5.95e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.67e-06	5.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.63e-06	5.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.6e-06	5.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.59e-06	5.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.56e-06	5.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	3.5e-06	5.66e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	3.44e-06	5.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—POMC—epilepsy syndrome	3.43e-06	5.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.42e-06	5.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.42e-06	5.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.41e-06	5.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.41e-06	5.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	3.38e-06	5.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	3.37e-06	5.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	3.35e-06	5.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	3.34e-06	5.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	3.31e-06	5.34e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	3.28e-06	5.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	3.27e-06	5.29e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	3.24e-06	5.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	3.19e-06	5.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	3.16e-06	5.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	3.16e-06	5.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	3.15e-06	5.09e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	3.15e-06	5.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	3.14e-06	5.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—epilepsy syndrome	3.13e-06	5.05e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	3.12e-06	5.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	3.11e-06	5.02e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	3.07e-06	4.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	2.99e-06	4.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.9e-06	4.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.88e-06	4.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.87e-06	4.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.84e-06	4.59e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.82e-06	4.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.81e-06	4.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.78e-06	4.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.75e-06	4.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.74e-06	4.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.68e-06	4.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.54e-06	4.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.54e-06	4.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.51e-06	4.06e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.36e-06	3.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.35e-06	3.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.33e-06	3.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.32e-06	3.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.31e-06	3.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.29e-06	3.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.15e-06	3.47e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.14e-06	3.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.13e-06	3.44e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.12e-06	3.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.12e-06	3.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.1e-06	3.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.07e-06	3.34e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.06e-06	3.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.04e-06	3.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.01e-06	3.25e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.01e-06	3.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.99e-06	3.21e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.95e-06	3.16e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.95e-06	3.14e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.93e-06	3.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.86e-06	3e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.85e-06	2.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.83e-06	2.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.81e-06	2.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.8e-06	2.91e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.78e-06	2.88e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.71e-06	2.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.38e-06	2.22e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-06	1.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-06	1.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.14e-06	1.84e-05	CbGpPWpGaD
